✦ LIBER ✦

Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated-interferon plus ribavirin therapy for chronic hepatitis C

✍ Scribed by Kurosaki, Masayuki; Tanaka, Yasuhito; Nishida, Nao; Sakamoto, Naoya; Enomoto, Nobuyuki; Matsuura, Kentaro; Asahina, Yasuhiro; Nakagawa, Mina; Watanabe, Mamoru; Sakamoto, Minoru; Maekawa, Shinya; Tokunaga, Katsushi; Mizokami, Masashi; Izumi, Namiki

Book ID: 118763142
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 285 KB
Volume: 85
Category: Article
ISSN: 0146-6615
DOI: 10.1002/jmv.23497

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1128 PREDICTION MODEL OF ANEMIA USING IT

1128 PREDICTION MODEL OF ANEMIA USING ITPA GENOTYPE IDENTIFIES PATIENTS AT HIGH RISK OF ANEMIA AND TREATMENT FAILURE WITH PEGYLATED-INTERFERON PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C

✍ Kurosaki, M.; Itakura, J.; Tsuchiya, K.; Nakanishi, H.; Asahina, Y.; Mizokami, M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Prediction of nonSVR to therapy with peg

Prediction of nonSVR to therapy with pegylated interferon-α2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment

✍ E. Lukasiewicz; M. Gorfine; L. S. Freedman; J.-M. Pawlotsky; S. W. Schalm; C. Fe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB